<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: July 24, 1997
Columbia/HCA Healthcare Corporation
- ------------------------------------------------------------------------------
(Exact Name of Registrant as specified in its Charter)
Delaware 001-11239 75-2497104
- ------------------------------------------------------------------------------
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
or corporation) Identification No.)
One Park Plaza
Nashville, Tennessee 37203
- ------------------------------------------------------------------------------
(Address of Principal (Zip Code)
Executive Offices)
Registrant's telephone number, including area code: (615) 344-9551
---------------------------
N/A
- ------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS
On July 16, 1997, various Columbia/HCA Healthcare Corporation ("Columbia"
or the "Company") affiliated facilities and offices in Florida, North Carolina,
Oklahoma, Tennessee, Texas and Utah were searched pursuant to search warrants
issued by the United States District Court in those states. In total, search
warrants were served on 18 Columbia affiliated hospitals and 15 other Columbia
affiliated locations. It appears that the focus of the government's
investigation is on outpatient laboratory billing and home health. Grand Jury
Subpoenas related to the home health investigation were served on five employees
of Columbia subsidiaries for testimony before the Grand Jury. The Company also
received three extensive Subpoenas from the Department of Health & Human
Services - Office of Inspector General, two on the home health investigation and
one on the lab billing investigation as well as various authorized investigative
demands ("AID") from the Department of Justice on the lab billing issue. The
Company has hired counsel to represent it in both the home health and lab
billing investigations. Management believes that it is too early to anticipate
whether such actions/investigations will have a material adverse effect on the
Company's financial position or results of operations.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
COLUMBIA/HCA HEALTHCARE CORPORATION
Date: July 24, 1997 By: /s/ STEPHEN T. BRAUN
---------------------------------
Stephen T. Braun
Senior Vice President and
General Counsel
